|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 13 Apr 2024 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 6.1 H | 4.8 - 5.7 | % |
| Glucose [Mass/volume] in Blood | 72.6 | 70 - 99 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 19.6 | 7 - 50 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.9 | 0.6 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.8 | 8.5 - 10.4 | mg/dL |
| Sodium [Moles/volume] in Blood | 137.8 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.4 | 3.5 - 5 | mmol/L |
| Chloride [Moles/volume] in Blood | 104.9 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 26.8 | 24 - 29 | mmol/L |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows persistently elevated HbA1c (6.1% and 5.9%), indicating impaired glucose metabolism or possible prediabetes, despite normal to low fasting glucose. Renal function, electrolytes, and other parameters are within normal limits. Recommend further evaluation for glycemic control and consideration of lifestyle or therapeutic interventions to prevent progression to diabetes. |